Small Hospitals
Market Cap
₹5,163 ₹5,163 Cr.
P/E
45.43
PEG
1.91
PEG = P/E ÷ 5yr forward EPS CAGR
5yr forward EPS CAGR thesis · Base case

The thesis becomes live when Raipur converts commissioned beds into occupied, paying patients while Gurugram continues to absorb fixed costs; the nearest distinct catalyst is the South Delhi definitive-contract disclosure.

The bull path is driven by faster Raipur utilization, stronger Gurugram case mix and ARPOB, and an earlier South Delhi contribution; the bear path comes from Raipur ramp failure concurrent with Gurugram occupancy or realization pressure.

Execution risk is concentrated in new-facility ramp-up rather than the established flagship, so occupancy and contracting triggers are the key differentiators between scenarios.

Key Ratios

Debt to Equity
Debt to Equity
0.26
Div Yield (%)
Div Yield (%)
0.14
Individual < 2 lac
Individual < 2 lac
11.51 %
Institutions
Institutions
20.85 %
Market cap
Market cap
5,163 Cr
No. of Shareholders
No. of Shareholders
36,335
OPM (%)
OPM (%)
18.25 %
PE
PE
45.43
Prom Holding
Prom Holding
58.39 %
ROCE (%)
ROCE (%)
13.40
ROE (%)
ROE (%)
11.09
Sales
Sales
1,113 Cr
  • Artemis MedicareServ
  • Kovai Medical Center
  • Indraprastha Medical
  • TJI Hospitals
Last updated on 27 Aug 2026
  • Artemis runs Gurgaon-centred multi-specialty hospitals; ~99% revenue from hospital services; per management ~95% revenue from Gurgaon
  • Earnings rest on high-acuity mix and international patients ~27% of revenue at ~1.3x domestic bed rates; scale and cost discipline help
  • ₹800 Cr build adds Tower IV pediatric/OB-GYN wing and South Delhi flagship toward ~2,000 beds; per management asset-light plus selective builds
  • Large build against light debt; conditional ₹700 Cr equity raise for brownfield assets per management shapes funding
  • Near term hinges on Raipur ramp; Gurgaon occupancy and margins guided ~70% and 20–21%
  • Faces ₹63 Cr GST demand on inpatient medicines; court writ outcome decides cash liability
  • Raipur ramp and insurance in 8–10 weeks; breakeven 15–18 months from Jul 2026
    losses against ~₹20 Cr path and shift to direct payors shape ramp
  • Gurgaon occupancy and margin print early/mid-Nov 2026
    shows ~70% occupancy and 20–21% margins plus case mix
  • ₹700 Cr enabling fundraise Feb–Apr 2027
    size, dilution and brownfield asset quality set funding for builds
  • Tower IV 200+ beds 18–22 months after clearances
    adds pediatric/OB-GYN capacity at ~₹120 Cr; break-even 8–10 months after opening
  • VIMHANS South Delhi 650+ beds Q4FY29
    adds large South Delhi flagship at ₹350–360 Cr plus deposits; funding decides pace
Price Range

See where the stock is trading versus its 52-week high and low.

Low
203
52W Range
High
362
Timeline

Key company specific updates.

Custom financial statement

Edit rows

Forensics

11 Yes

Positive for this company

2 Neutral

Neutral for this company

4 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Therapeutic Area Break-Up

Asset Break-Up - Geography Wise

Operational Metrics

    Select a Metric
    • Hospital Occupancy Rate (%)
    • Average Length Of Stay (Days)
    • Average Daily Revenue Per Occupied Bed (Rs)
    • Number of Outpatient Visits - Quarterly (.)
    • Number of Surgeries - Quarterly (.)

    Peer Comparison

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    FAQs on Artemis Medicare Services Ltd. Business

    Artemis Medicare Services Ltd is a healthcare company and a Sister Concern Of Apollo Tyres Limited. It owns and operates a multi specialty hospital in Gurgaon providing cardiovascular, orthopaedic, oncology, and neurosciences services.

    Artemis MedicareServ major competitors are Kovai Medical Center, Indraprastha Medical, Dr Agarwals Eye Hosp, KMC Speciality Hosp., Jupiter Life Line, Yatharth Hospital, Shalby.
    Market Cap of Artemis MedicareServ is ₹5,452 Crs.
    While the median market cap of its peers are ₹3,248 Crs.

    Artemis MedicareServ seems to be less financially stable compared to its competitors.
    Altman Z score of Artemis MedicareServ is 7.45 and is ranked 6 out of its 8 competitors.

    Company Filing

    2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Feb May Aug May Aug Mar Jun Sep Dec Mar Jun Sep Dec Sep Dec
    Investor Presentation Feb May Aug May Aug Nov Mar Jun Sep Dec Mar Jun Sep Dec Sep Dec
    Conference Call Feb May Aug Nov
    Conference Call SummaryCon Call Summary

    Discussions & Analysis

    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material